Wuhan Union Hospital, China: Colorectal Neoplasms trials

The registry lists 15 Colorectal Neoplasms studies with Wuhan Union Hospital, China as lead sponsor. 7 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 2Phase 2 7No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies）Not yet recruitingNCT07007767Phase 2
• A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal CancerRecruitingNCT06717880Phase 1
• Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal CancerRecruitingNCT06347198Early Phase 1
• Fruquintinib in the Cross-line Treatment of Refractory mCRCRecruitingNCT06099314
• Molecular Study and Precision Medicine for Colorectal CancerNot yet recruitingNCT05883683
• SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRCNot yet recruitingNCT05747716Phase 2
• Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal ChemotherapyNot yet recruitingNCT04845490Phase 2
• [68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant TherapyCompletedNCT06982053Not applicable
• Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal CancerStatus unknownNCT05635149
• Effects of Incomplete ERAS on Clinical Outcomes in Patients With Colorectal CancerStatus unknownNCT05412355
• A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastric and Colorectal Cancer Patients With FGFR Alterations Who Have Failed Standard TherapyStatus unknownNCT05202236Phase 2
• Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRCStatus unknownNCT05155124Phase 1
• Safety and Efficacy Study of Chemotherapy Plus Apatinib as Second-line Therapy in Metastatic Colorectal CancerWithdrawnNCT03193814Phase 2
• Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal CancerStatus unknownNCT03142282Phase 2
• Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency AblationWithdrawnNCT03135652Phase 2